Reduced intensity hematopoietic stem cell transplantation for accelerated-phase myelofibrosis

Accelerated-phase myelofibrosis, currently defined by circulating blasts 10% to 19%, usually confers very high risk for progression and poor outcome. The outcome of hematopoietic stem cell transplantation for accelerated-phase myelofibrosis has not been evaluated yet. We analyzed the outcome of 349...

Descripción completa

Detalles Bibliográficos
Autores principales: Gagelmann, Nico, Wolschke, Christine, Salit, Rachel B., Schroeder, Thomas, Ditschkowski, Markus, Panagiota, Victoria, Cassinat, Bruno, Thol, Felicitas, Badbaran, Anita, Robin, Marie, Reinhardt, Hans Christian, Ayuk, Francis, Heuser, Michael, Scott, Bart L., Kröger, Nicolaus
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Hematology 2022
Materias:
Clinical Trials and Observations
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864646/
https://www.ncbi.nlm.nih.gov/pubmed/35051996
http://dx.doi.org/10.1182/bloodadvances.2021006827

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8864646/
https://www.ncbi.nlm.nih.gov/pubmed/35051996
http://dx.doi.org/10.1182/bloodadvances.2021006827

Ejemplares similares